Biogen (NASDAQ:BIIB) is gearing up to announce its quarterly earnings on Thursday, 2025-10-30. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...
For decades, Biogen has built a legacy in neuroscience — having brought to market drugs that have changed lives for multiple sclerosis, Alzheimer’s disease, spinal muscular atrophy, and more. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results